These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 3900182)
1. Clonidine benefits children with attention deficit disorder and hyperactivity: report of a double-blind placebo-crossover therapeutic trial. Hunt RD; Minderaa RB; Cohen DJ J Am Acad Child Psychiatry; 1985 Sep; 24(5):617-29. PubMed ID: 3900182 [No Abstract] [Full Text] [Related]
2. Clonidine treatment of hyperactive and impulsive children with autistic disorder. Jaselskis CA; Cook EH; Fletcher KE; Leventhal BL J Clin Psychopharmacol; 1992 Oct; 12(5):322-7. PubMed ID: 1479049 [TBL] [Abstract][Full Text] [Related]
3. Double-blind, placebo-controlled trial of clonidine in hyperactive children with mental retardation. Agarwal V; Sitholey P; Kumar S; Prasad M Ment Retard; 2001 Aug; 39(4):259-67. PubMed ID: 11448249 [TBL] [Abstract][Full Text] [Related]
4. The therapeutic effect of clonidine in attention deficit disorder with hyperactivity: a comparison with placebo and methylphenidate. Hunt RD; Minderaa RB; Cohen DJ Psychopharmacol Bull; 1986; 22(1):229-36. PubMed ID: 3523578 [No Abstract] [Full Text] [Related]
6. Clonidine for treatment of attention-deficit/hyperactivity disorder. Med Lett Drugs Ther; 1996 Dec; 38(989):109-10. PubMed ID: 8957471 [No Abstract] [Full Text] [Related]
7. A review of the use of clonidine as a sleep aid in the child and adolescent population. Nguyen M; Tharani S; Rahmani M; Shapiro M Clin Pediatr (Phila); 2014 Mar; 53(3):211-6. PubMed ID: 24027233 [No Abstract] [Full Text] [Related]
8. The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: a double-blind placebo-controlled study with clonidine and desipramine. Singer HS; Brown J; Quaskey S; Rosenberg LA; Mellits ED; Denckla MB Pediatrics; 1995 Jan; 95(1):74-81. PubMed ID: 7770313 [TBL] [Abstract][Full Text] [Related]
9. Clonidine for attention-deficit/hyperactivity disorder: I. Efficacy and tolerability outcomes. Palumbo DR; Sallee FR; Pelham WE; Bukstein OG; Daviss WB; McDERMOTT MP; J Am Acad Child Adolesc Psychiatry; 2008 Feb; 47(2):180-188. PubMed ID: 18182963 [TBL] [Abstract][Full Text] [Related]
10. A placebo-controlled study of lofexidine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. Niederhofer H; Staffen W; Mair A J Psychopharmacol; 2003 Mar; 17(1):113-9. PubMed ID: 12680748 [TBL] [Abstract][Full Text] [Related]
11. Use of clonidine in children with autism spectrum disorders. Ming X; Gordon E; Kang N; Wagner GC Brain Dev; 2008 Aug; 30(7):454-60. PubMed ID: 18280681 [TBL] [Abstract][Full Text] [Related]
12. A double-blind, placebo-controlled study of the efficacy of transdermal clonidine in autism. Fankhauser MP; Karumanchi VC; German ML; Yates A; Karumanchi SD J Clin Psychiatry; 1992 Mar; 53(3):77-82. PubMed ID: 1548248 [TBL] [Abstract][Full Text] [Related]
17. Effect of tyrosine on attention deficit disorder with hyperactivity. Eisenberg J; Asnis GM; van Praag HM; Vela RM J Clin Psychiatry; 1988 May; 49(5):193-5. PubMed ID: 3284877 [TBL] [Abstract][Full Text] [Related]
18. A pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder. Connor DF; Barkley RA; Davis HT Clin Pediatr (Phila); 2000 Jan; 39(1):15-25. PubMed ID: 10660814 [TBL] [Abstract][Full Text] [Related]
19. [Indications for clonidine in child psychiatry]. Dollfus S Encephale; 1993; 19(2):83-7. PubMed ID: 8275901 [TBL] [Abstract][Full Text] [Related]
20. Safety of clonidine and nortriptyline. Chapman NA J Am Acad Child Adolesc Psychiatry; 1994 Jan; 33(1):142-3. PubMed ID: 8138513 [No Abstract] [Full Text] [Related] [Next] [New Search]